Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice

• Published in: Neuropharmacology 2012-08, Vol.63 (2), p.250-258
• Main Authors: Smith, Kiersten S., Engin, Elif, Meloni, Edward G., Rudolph, Uwe
• Format: Article
• Language: English
• Subjects: Animals; Anti-Anxiety Agents - pharmacology; Anti-Anxiety Agents - therapeutic use; Anxiety; Anxiety - drug therapy; Anxiety - genetics; Anxiety - metabolism; Anxiolytics; Behavior, Animal - drug effects; Behavior, Animal - physiology; Benzodiazepine; chlordiazepoxide; Chlordiazepoxide - pharmacology; Chlordiazepoxide - therapeutic use; Conditioned fear; Conditioning (Psychology) - drug effects; Conditioning (Psychology) - physiology; Diazepam; Diazepam - pharmacology; Diazepam - therapeutic use; Drugs; Fear - drug effects; Fear - physiology; Fear conditioning; Fear-potentiated startle; GABAA receptor; gamma -Aminobutyric acid A receptors; Male; Mice; Mice, Knockout; Mice, Mutant Strains; Protein Subunits - genetics; Protein Subunits - metabolism; Receptors, GABA-A - genetics; Receptors, GABA-A - metabolism; Reflex, Startle - drug effects; Reflex, Startle - physiology; α subunit
• ISSN: 0028-3908; 1873-7064
• DOI: 10.1016/j.neuropharm.2012.03.001

GABAA receptor modulating drugs such as benzodiazepines (BZs) have been used to treat anxiety disorders for over five decades. In order to determine whether the same or different GABAA receptor subtypes are necessary for the anxiolytic-like action of BZs in unconditioned anxiety and conditioned fear models, we investigated the role of different GABAA receptor subtypes by challenging wild type, α1(H101R), α2(H101R) and α3(H126R) mice bred on the C57BL/6J background with diazepam or chlordiazepoxide in the elevated plus maze and the fear-potentiated startle paradigms. Both drugs significantly increased open arm exploration in the elevated plus maze in wild type, α1(H101R) and α3(H126R), but this effect was abolished in α2(H101R) mice; these were expected results based on previous published results. In contrast, while administration of diazepam and chlordiazepoxide significantly attenuated fear-potentiated startle (FPS) in wild type mice and α3(H126R) mice, the fear-reducing effects of these drugs were absent in both α1(H101R) and α2(H101R) point mutants, indicating that both α1- and α2-containing GABAA receptors are necessary for BZs to exert their effects on conditioned fear responses. Our findings illustrate both an overlap and a divergence between the GABAA receptor subtype requirements for the impact of BZs, specifically that both α1- and α2-containing GABAA receptors are necessary for BZs to reduce conditioned fear whereas only α2-containing GABAA receptors are needed for BZ-induced anxiolysis in unconditioned tests of anxiety. This raises the possibility that GABAergic pharmacological interventions for specific anxiety disorders can be differentially tailored. ► We used H–R point mutated mice to study benzodiazepine effects on anxiety and fear. ► α2-subunits are required for benzodiazepine-induced anxiolysis in elevated plus maze. ► α1- and α2-subunits are required for benzodiazepine-induced reduction of conditioned fear. ► Pharmacological interventions for specific anxiety disorders can be differentially tailored.